Standard: this guide onlyAll-Access Lifetime: all 45 guides + downloadsEducational content only
NA-Semax Amidate Guide: Available Now
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.
NA-Semax Amidate at a glance
What it is
A stabilized synthetic analog of Semax (an ACTH(4-10) heptapeptide fragment), modified with N-terminal acetylation and C-terminal amidation to resist enzymatic breakdown
Researched for
Studied in cognition, memory, focus, neuroprotection and mood research contexts (largely via the parent Semax literature)
Commonly reported range
Approximately 300-900 mcg per day in community and vendor protocols (examples, not a recommendation)
Route reported
Intranasal (most commonly reported) or subcutaneous injection
Reported frequency
Once to three times daily in reported protocols
Reported cycle
Roughly 30-60 days with a washout period, as commonly described
Plasma half-life
Short — reported near ~30 minutes for the modified peptide vs. a few minutes for standard Semax, though downstream neurotrophic effects are reported to persist longer
Regulatory status
Not FDA-approved; research-use-only in the US. Parent Semax is approved as a medication in Russia. Not explicitly named on the WADA list but may fall under WADA S0
Reported ranges from research/community — examples, not recommendations.
What it is / mechanism
N-Acetyl Semax Amidate is a chemically modified version of Semax, itself a synthetic fragment analog of the ACTH(4-10) region of adrenocorticotropic hormone. The N-terminal acetyl group and C-terminal amide group are reported to slow degradation by aminopeptidases and carboxypeptidases, which is thought to extend the peptide's functional stability relative to unmodified Semax. In research literature the Semax family is described as crossing the blood-brain barrier and upregulating neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), along with their associated TrkB receptor signaling. Semax is also reported to modulate the dopaminergic, serotonergic and enkephalin (opioid) systems, which are involved in mood, attention, stress response and reward. Because NA-Semax Amidate has not been independently studied in humans, essentially all of these mechanisms are extrapolated from the parent Semax research rather than demonstrated for the modified analog itself.
Researched effects
In the parent Semax research and in community reports, the Semax family is associated with improved focus, working memory, mental clarity, and a mild stimulant-like alertness, along with reported neuroprotective and stress-buffering effects. Some studies of Semax report BDNF elevation and increased TrkB expression, with peak neurotrophic upregulation described several hours after administration. These are research findings and community-reported observations, not guaranteed outcomes; individual responses vary and NA-Semax Amidate itself has not been the subject of dedicated clinical trials.
Evidence & regulatory status
Evidence: Most human evidence comes from the parent compound Semax (studied in Russia for cognition, stroke recovery and neuroprotection); N-Acetyl Semax Amidate is a vendor-modified analog whose properties are largely inferred from that Semax literature rather than independently proven.
Regulatory: Not FDA-approved and sold in the US for research use only. Parent Semax is an approved medication in Russia; the acetylated/amidated analog is not separately classified. Not explicitly named on the 2026 WADA Prohibited List, though non-approved substances can fall under WADA category S0.
Research-use: Provided strictly as a research chemical for laboratory and educational purposes. Content here describes what is reported in studies and community discussion and is not a recommendation for human use.
Dosage — reported ranges (overview)
The figures below are examples of what is reported in vendor and community protocols, not a recommendation or a personal dose. Intranasal use is the most commonly reported route, with reported daily totals around 300-900 mcg (for example ~600 mcg/day), often split into one to three administrations. Subcutaneous protocols are reported in a similar range (roughly 250-1000 mcg/day). Reported cycles typically run 30-60 days followed by a washout period, with lower daily amounts used for longer cycles and higher amounts reserved for shorter ones. Because the modified analog is more resistant to degradation than standard Semax, some sources report using amounts modestly lower than typical Semax protocols.
The full step-by-step protocol examples, titration, and printable protocol sheet are planned for a future paid Protocol Playbook module.
Reconstitution — bac-water math
Reconstitution here is concentration math only — it defines how much peptide sits in each unit of liquid, not a personal dose. NA-Semax Amidate is dosed in micrograms (mcg), so on a standard U-100 insulin syringe (100 units = 1 mL) the concentration in mcg/mL is total peptide mcg divided by the water volume in mL, and the units to draw for a target dose D (mcg) are D ÷ (mcg/mL) × 100. Worked example: reconstituting a 10 mg (10,000 mcg) vial with 2 mL of bacteriostatic water gives 5,000 mcg/mL; a 300 mcg example dose is 300 ÷ 5,000 × 100 = 6 units, and a 900 mcg example is 18 units. Add water slowly down the vial wall to avoid foaming and do not shake.
Bac water added
Concentration
300 mcg (low example)
900 mcg (high example)
1 mL
10,000 mcg/mL (10 mg/mL)
3 units (0.03 mL)
9 units (0.09 mL)
2 mL
5,000 mcg/mL (5 mg/mL)
6 units (0.06 mL)
18 units (0.18 mL)
3 mL
3,333 mcg/mL (~3.33 mg/mL)
9 units (0.09 mL)
27 units (0.27 mL)
This is concentration math, not a dose recommendation.
Pre-fills example values. Every field remains editable.
The amount printed on the vial or listed on a product page.
mL
Liquid volume used for the concentration calculation.
The mass amount to convert into liquid volume for this math example.
4. Insulin syringe size
Your result
Syringe-unit reading
6 units
= 0.06 mL · 300 mcg target amount
Concentration
5mg/mL
Per insulin unit
50mcg
Portions per vial
33.3
Volume
0.06mL
This calculator is an educational tool for laboratory and research math only. The peptides referenced are research compounds not intended for human or veterinary use, and example values are not medical advice or personal-use instructions. Follow applicable research protocols and regulations.
How the calculator works
Concentration
peptide ÷ liquid
Total peptide divided by liquid volume gives the concentration per mL.
Volume
target ÷ concentration
The target mass divided by concentration gives the liquid volume.
Syringe units
volume × 100
For insulin units, 100 units equals 1 mL, so mL is multiplied by 100.
Worked example: A 5 mg vial plus 2 mL liquid creates a 2.5 mg/mL concentration. A 250 mcg target amount equals 0.1 mL, or 10 insulin units. The vial contains 20 such portions.
Frequently asked questions
How much bacteriostatic water should I enter?+
There is no single calculator-default amount. The liquid volume controls concentration: more liquid creates a less concentrated solution and a larger volume reading for the same target amount; less liquid creates a more concentrated solution and a smaller volume reading.
How do insulin syringe units relate to mL?+
For this math tool, 100 insulin units equals 1 mL, and 1 unit equals 0.01 mL. The 0.3 mL, 0.5 mL, and 1.0 mL options change capacity, not the unit-to-mL relationship.
What is the difference between mg, mcg, and units?+
Milligrams and micrograms measure peptide mass: 1 mg = 1,000 mcg. Syringe units measure liquid volume. Reconstitution math connects mass and volume by using concentration.
Does changing the liquid volume change the total peptide in the vial?+
No. The total peptide amount entered for the vial remains fixed. Changing the liquid volume only changes concentration and the resulting volume shown by the calculator.
Injection / administration basics
For subcutaneous research handling, reported practice uses a small insulin syringe (30- or 50-unit) for accuracy at these low microgram volumes, drawing into subcutaneous tissue of the abdomen, thigh or upper arm at roughly a 45-degree angle, rotating sites. For the intranasal route, formulations are dispensed as a metered spray (commonly 0.1% or 0.3%, delivering about 300 mcg per pump), with a pause of about 60 seconds between applications to each nostril. All of this is descriptive of reported handling, not medical instruction.
Half-life & frequency rationale
The plasma half-life is short. Standard Semax is reported to clear within minutes, and the acetyl/amide modification in NA-Semax Amidate is reported to extend that to roughly 30 minutes (some vendor sources cite a longer functional window of a few hours). Downstream neurotrophic effects such as BDNF upregulation are reported in Semax studies to build over several hours and persist well beyond the peptide's presence in circulation. Precise pharmacokinetics for the modified analog are not well characterized in the literature.
Side effects, safety & contraindications
Human safety data for NA-Semax Amidate specifically is very limited, and most safety information is inferred from the parent Semax. Reported and anticipated effects include stimulant-like overstimulation or anxiety at higher amounts, irritability or disrupted sleep, and — with intranasal use — nasal or throat irritation. Subcutaneous use may produce local injection-site reactions such as redness, swelling or discomfort. Some sources caution against combining it with other nootropics given the limited safety data. None of this substitutes for professional medical evaluation.
Stacking — overview
In community and vendor discussion, the most established pairing is Semax with Selank (or their modified analogs, NA-Semax Amidate with NA-Selank Amidate): Semax is described as providing dopaminergic and BDNF-mediated cognitive stimulation while Selank contributes anxiolytic, GABAergic stabilization, with the idea that Selank smooths out the stimulating edge of Semax. These are reported examples of how researchers describe combining them, not recommendations, and some sources advise caution when stacking due to sparse safety data. From our library, the peptides most often mentioned alongside NA-Semax Amidate are listed below.
Semax + Selank ("nootropic pair")
NA-Semax Amidate for focus/BDNF with Selank (or NA-Selank Amidate) for anxiolytic balance — the most commonly discussed combination
Cognition + neuroprotection
NA-Semax Amidate with Epithalon, reported in longevity/neuroprotection-oriented discussion
Recovery-oriented pairing
NA-Semax Amidate alongside BPC-157, reported by users pursuing general recovery and neurological support
Sleep counterbalance
NA-Semax Amidate (daytime) with DSIP, reported to offset stimulant-like effects that can disrupt sleep
Storage & handling
Lyophilized (freeze-dried) powder is reported to be stable refrigerated at 2-8°C, and can be kept frozen for longer-term storage; keep it away from light and moisture until reconstituted.
Once reconstituted with bacteriostatic water, it should be refrigerated at 2-8°C and used within a few weeks; avoid freezing the reconstituted solution and do not shake.
References
Information is compiled from the published Semax research literature and from vendor and community sources such as Peptides.org, Peptidepedia and related peptide databases; because N-Acetyl Semax Amidate has not been independently studied in humans, most facts are extrapolated from the parent Semax and presented for educational use only.
Related peptide guides
Continue exploring related educational guide topics in the Medibact library.
Quick answers about guide scope, access, and educational use context.
How is N-Acetyl Semax Amidate different from regular Semax?
It is standard Semax with two chemical modifications — an acetyl group added to the N-terminus and an amide group on the C-terminus. These are reported to slow enzymatic breakdown, giving the analog greater stability and a somewhat longer functional window than unmodified Semax. Note that the analog itself has not been independently studied; its properties are inferred from the Semax literature.
Is it taken as a nasal spray or an injection?
Both routes are reported. Intranasal use (a metered spray) is the most commonly described route in the community, while subcutaneous injection is also used. This guide describes reported practice, not a recommendation to use it either way.
What dose is commonly reported?
Reported protocols cluster around 300-900 mcg per day (for example ~600 mcg/day), split into one to three administrations. These are examples of what is reported, not a personal dose or recommendation.
Is N-Acetyl Semax Amidate legal or approved?
It is not FDA-approved and is sold in the US for research use only. The parent compound Semax is an approved medication in Russia, but the acetylated/amidated analog is not separately classified there. It is not explicitly named on the 2026 WADA list, though non-approved substances can fall under WADA category S0 for athletes.
How long do reported cycles last?
Community and vendor sources commonly describe cycles of about 30-60 days followed by a washout period, with lower daily amounts used for longer runs. This is descriptive of reported practice only.
Compliance and trust notes
Educational content only; no personalized health or outcome claims.
No personalized use recommendation outputs.
Use this material for general learning and research-context literacy.
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.
